Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BJU International|August 4, 2015
The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic reviewMaudy Gayet, Anouk van der Aa, Harrie P Beerlage, et al.European Urology Focus|July 30, 2017
Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical CohortMaudy Gayet, Christophe K Mannaerts, Daan Nieboer, et al.World Journal of Urology|February 6, 2016
3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detectionMaudy Gayet, Anouk van der Aa, Peter Schmitz, et al.Journal of Ultrasound|August 1, 2018
Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathologyRogier R Wildeboer, Ruud J G van Sloun, Arnoud W Postema, et al.European Urology Focus|April 28, 2019
Deep Learning for Real-time, Automatic, and Scanner-adapted Prostate (Zone) Segmentation of Transrectal Ultrasound, for Example, Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate BiopsyRuud J G van Sloun, Rogier R Wildeboer, Christophe K Mannaerts, et al.World Journal of Urology|February 3, 2018
Concordance of Gleason grading with three-dimensional ultrasound systematic biopsy and biopsy core pre-embeddingAnouk A M A van der Aa, Christophe K Mannaerts, Hans van der Linden, et al.Urologic Oncology|January 21, 2019
The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsyChristophe K Mannaerts, Amir Kajtazovic, Olivia A P Lodeizen, et al.European Urology Oncology|May 18, 2019
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS BiopsyChristophe K Mannaerts, Maudy Gayet, Jan F Verbeek, et al.Pageof 1